Short peptide analogs as alternatives to collagen in pro-regenerative corneal implants. (15th March 2018)

• Record Type: Journal Article
• Authors: Jangamreddy, Jaganmohan R.; Haagdorens, Michel K.C.; Mirazul Islam, M.; Lewis, Philip; Samanta, Ayan; Fagerholm, Per; Liszka, Aneta; Ljunggren, Monika K.; Buznyk, Oleksiy; Alarcon, Emilio I.; Zakaria, Nadia; Meek, Keith M.; Griffith, May
• Is Part Of: Acta biomaterialia. Volume 69(2018)
• Page Start: 120
• Page End: 130
• Publication Date: 2018-03-15
• Subjects: Collagen-like peptide -- Recombinant human collagen -- Cornea -- Regeneration -- Exosomes; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2018.01.011
• Languages: English
• ISSNs: 1742-7061

Abstract

Graphical abstract: Abstract: Short collagen-like peptides (CLPs) are being proposed as alternatives to full-length collagen for use in tissue engineering, on their own as soft hydrogels, or conjugated to synthetic polymer for mechanical strength. However, despite intended clinical use, little is known about their safety and efficacy, mechanism of action or degree of similarity to the full-length counterparts they mimic. Here, we show the functional equivalence of a CLP conjugated to polyethylene glycol (CLP-PEG) to full-length recombinant human collagen in vitro and in promoting stable regeneration of corneal tissue and nerves in a pre-clinical mini-pig model. We also show that these peptide analogs exerted their pro-regeneration effects through stimulating extracellular vesicle production by host cells. Our results support future use of CLP-PEG implants for corneal regeneration, suggesting the feasibility of these or similar peptide analogs in clinical application in the eye and other tissues. Statement of significance: Although biomaterials comprising full-length recombinant human collagen and extracted animal collagen have been evaluated and used clinically, these macromolecules provide only a limited number of functional groups amenable to chemical modification or crosslinking and are demanding to process. Synthetic, customizable analogs that are functionally equivalent, and can be readily scaled-up are therefore very desirable for pre-clinical to clinical translation. Here, we demonstrate, using cornea regeneration as our test bed, that collagen-like-peptides conjugated to multifunctional polyethylene glycol (CLP-PEG) when grafted into mini-pigs as corneal implants were functionally equivalent to recombinant human collagen-based implants that were successfully tested in patients. We also show for the first time that these materials affected regeneration through stimulation of extracellular vesicle production by endogenous host cells that have migrated into the CLP-PEG scaffolds.